Alvotech wins FDA approval for Simlandi production method that doubles batch output

Bitget2026/10/20 08:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Alvotech received FDA approval today for a new manufacturing process that doubles active ingredient output per batch for Simlandi, its Humira biosimilar.
The process requires more than 50% fewer batches for the same Simlandi volume, freeing capacity for other biosimilars.
FDA clearance earlier this month for a new manufacturing unit in Reykjavík also significantly increases production capacity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alvotech SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610200430OMX_____CNEWS_IS_GNW1001278774_is) on October 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Alvotech wins FDA approval for Simlandi production method that doubles batch output

You may also like

Crypto prices